Events

MSCA Radiance Online event for MSCA Postdoctoral Fellowships opportunities in Widening Countries
APR
Mon
27
09:30 - 11:00

This was 3 weeks ago

Location

Online

Programmes
MSCA Widening/Spreading

This MSCA Radiance webinar is dedicated to researchers planning to apply for the MSCA Postdoctoral Fellowships with a Widening Country.
This session will include:

Information on Widening Countries is available on the European Commission Research Executive Agency website here.

All information related to this webinar, including the registration form and full agenda, is available in the announcement on the Horizon Europe NCP Portal website.

Agenda in brief (CET)

9.30 Welcome and introduction

9.35 PF highlights

9.45 Presentation of opportunities in Malta

9.55 Presentation of opportunities in Poland

10.05 Presentation of opportunities in Estonia

10.15 Presentation of opportunities in Lithuania

10.25 Presentation of opportunities in Bulgaria

10.35 Questions and answers

11.00 End of event

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.